Show simple item record

dc.contributor.authorFredrikson, GNen_US
dc.contributor.authorAnand, DVen_US
dc.contributor.authorHopkins, Den_US
dc.contributor.authorCorder, Ren_US
dc.contributor.authorAlm, Ren_US
dc.contributor.authorBengtsson, Een_US
dc.contributor.authorShah, PKen_US
dc.contributor.authorLahiri, Aen_US
dc.contributor.authorNilsson, Jen_US
dc.date.accessioned2016-09-30T17:08:17Z
dc.date.available2009-04-01en_US
dc.date.issued2009-07en_US
dc.date.submitted2016-09-16T11:19:23.758Z
dc.identifier.issn0012-186Xen_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/15670
dc.description.sponsorshipSupported by grants from the Swedish Medical Research Council, the Swedish Heart-Lung foundation, the Söderberg foundation, the Albert Påhlsson foundation, the Knut and Alice Wallenberg foundation, the Malmö University Hospital foundation, the Lundström Foundation, the Crafoord Foundation, the Harrow Cardiovascular Research Trust, Michael Tabor Foundation, GE Healthcare, Bristol Myers Squibb Medical Imaging and the Derrick Smith Research Grant.en_US
dc.format.extent1426 - 1433en_US
dc.language.isoenen_US
dc.relation.ispartofDIABETOLOGIAen_US
dc.rightsThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
dc.rightsThe final publication is available at Springer via http://dx.doi.org/10.1007/s00125-009-1377-9
dc.subjectAntibodiesen_US
dc.subjectLow-density lipoproteinen_US
dc.subjectOxidationen_US
dc.subjectPeripheral neuropathyen_US
dc.subjectRetinopathyen_US
dc.subjectCORONARY-ARTERY-DISEASEen_US
dc.subjectLOW-DENSITY-LIPOPROTEINen_US
dc.subjectALDEHYDE-MODIFIED PEPTIDEen_US
dc.subjectOXIDIZED LDLen_US
dc.subjectHYPERCHOLESTEROLEMIC RABBITSen_US
dc.subjectIMMUNE-RESPONSESen_US
dc.subjectDEFICIENT MICEen_US
dc.subjectRISK-FACTORSen_US
dc.subjectATHEROSCLEROSISen_US
dc.subjectIMMUNIZATIONen_US
dc.titleAssociations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetesen_US
dc.typeArticle
dc.rights.holder(c) 2009 The Authors
dc.identifier.doi10.1007/s00125-009-1377-9en_US
pubs.issue7en_US
pubs.notesNot knownen_US
pubs.volume52en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record